LHON Main Diagnostic de la NOHL : sensibiliser le public à la souffran... Maryse Roger a vécu de près la neuropathie optique héréditaire de Leber (NOHL).
Views & Analysis LHON diagnosis: Opening peoples’ eyes to the invisible suffe... Maryse Roger has firsthand experience of Leber’s hereditary optic neuropathy (LHON), having first assisted her two brothers as their sight deteriorated and then leading the care of her son
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
